Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
PLoS One ; 9(11): e112102, 2014.
Article in English | MEDLINE | ID: mdl-25372608

ABSTRACT

BACKGROUND: The simple and well-described structure of the C. elegans nervous system offers an unprecedented opportunity to identify the genetic programs that define the connectivity and function of individual neurons and their circuits. A correspondingly precise gene expression map of C. elegans neurons would facilitate the application of genetic methods toward this goal. Here we describe a powerful new approach, SeqCeL (RNA-Seq of C. elegans cells) for producing gene expression profiles of specific larval C. elegans neurons. METHODS AND RESULTS: We have exploited available GFP reporter lines for FACS isolation of specific larval C. elegans neurons for RNA-Seq analysis. Our analysis showed that diverse classes of neurons are accessible to this approach. To demonstrate the applicability of this strategy to rare neuron types, we generated RNA-Seq profiles of the NSM serotonergic neurons that occur as a single bilateral pair of cells in the C. elegans pharynx. These data detected >1,000 NSM enriched transcripts, including the majority of previously known NSM-expressed genes. SIGNIFICANCE: This work offers a simple and robust protocol for expression profiling studies of post-embryonic C. elegans neurons and thus provides an important new method for identifying candidate genes for key roles in neuron-specific development and function.


Subject(s)
Caenorhabditis elegans , Gene Expression Profiling , Neurons , Animals , Caenorhabditis elegans/cytology , Caenorhabditis elegans/metabolism , Cell Separation/methods , Gene Expression Regulation/physiology , Neurons/cytology , Neurons/metabolism
2.
Genome Res ; 23(10): 1749-62, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23800452

ABSTRACT

We have created a library of 2007 mutagenized Caenorhabditis elegans strains, each sequenced to a target depth of 15-fold coverage, to provide the research community with mutant alleles for each of the worm's more than 20,000 genes. The library contains over 800,000 unique single nucleotide variants (SNVs) with an average of eight nonsynonymous changes per gene and more than 16,000 insertion/deletion (indel) and copy number changes, providing an unprecedented genetic resource for this multicellular organism. To supplement this collection, we also sequenced 40 wild isolates, identifying more than 630,000 unique SNVs and 220,000 indels. Comparison of the two sets demonstrates that the mutant collection has a much richer array of both nonsense and missense mutations than the wild isolate set. We also find a wide range of rDNA and telomere repeat copy number in both sets. Scanning the mutant collection for molecular phenotypes reveals a nonsense suppressor as well as strains with higher levels of indels that harbor mutations in DNA repair genes and strains with abundant males associated with him mutations. All the strains are available through the Caenorhabditis Genetics Center and all the sequence changes have been deposited in WormBase and are available through an interactive website.


Subject(s)
Caenorhabditis elegans/genetics , Genes, Helminth , Mutation , Alleles , Animals , Caenorhabditis elegans/classification , Codon, Nonsense , DNA Copy Number Variations , DNA, Ribosomal , Databases, Nucleic Acid , Genes, Essential , Genes, Suppressor , Genetic Variation , Genome, Helminth , Genome, Mitochondrial , Heterozygote , INDEL Mutation , Male , Mutation, Missense , Phenotype , Polymorphism, Single Nucleotide , Tandem Repeat Sequences
3.
Antimicrob Agents Chemother ; 57(5): 2204-15, 2013 May.
Article in English | MEDLINE | ID: mdl-23459479

ABSTRACT

Pseudomonas aeruginosa can develop resistance to polymyxin as a consequence of mutations in the PhoPQ regulatory system, mediated by covalent lipid A modification. Transposon mutagenesis of a polymyxin-resistant phoQ mutant defined 41 novel loci required for resistance, including two regulatory systems, ColRS and CprRS. Deletion of the colRS genes, individually or in tandem, abrogated the polymyxin resistance of a ΔphoQ mutant, as did individual or tandem deletion of cprRS. Individual deletion of colR or colS in a ΔphoQ mutant also suppressed 4-amino-L-arabinose addition to lipid A, consistent with the known role of this modification in polymyxin resistance. Surprisingly, tandem deletion of colRS or cprRS in the ΔphoQ mutant or individual deletion of cprR or cprS failed to suppress 4-amino-L-arabinose addition to lipid A, indicating that this modification alone is not sufficient for PhoPQ-mediated polymyxin resistance in P. aeruginosa. Episomal expression of colRS or cprRS in tandem or of cprR individually complemented the Pm resistance phenotype in the ΔphoQ mutant, while episomal expression of colR, colS, or cprS individually did not. Highly polymyxin-resistant phoQ mutants of P. aeruginosa isolated from polymyxin-treated cystic fibrosis patients harbored mutant alleles of colRS and cprS; when expressed in a ΔphoQ background, these mutant alleles enhanced polymyxin resistance. These results define ColRS and CprRS as two-component systems regulating polymyxin resistance in P. aeruginosa, indicate that addition of 4-amino-L-arabinose to lipid A is not the only PhoPQ-regulated biochemical mechanism required for resistance, and demonstrate that colRS and cprS mutations can contribute to high-level clinical resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Drug Resistance, Bacterial/drug effects , Gene Expression Regulation, Bacterial/drug effects , Genes, Regulator/drug effects , Polymyxins/pharmacology , Pseudomonas aeruginosa/drug effects , Arabinose/analogs & derivatives , Arabinose/metabolism , Bacterial Proteins/metabolism , Cystic Fibrosis/drug therapy , Cystic Fibrosis/microbiology , DNA Transposable Elements , Drug Resistance, Bacterial/genetics , Gene Deletion , Genetic Complementation Test , Genetic Loci , Humans , Lipid A/metabolism , Mutation , Plasmids , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Pseudomonas aeruginosa/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL